HDFC Life Insurance sold 2,75,000 shares of Sanofi India for ₹86.62 Cr at ₹3150.00 apiece in a bulk deal.
A leading multinational pharmaceutical company operating in India, Sanofi India manufactures and distributes medicines across multiple therapeutic areas including diabetes, cardiology, thrombosis, central nervous system disorders, and anti-histamines. The company serves patients and healthcare providers through a comprehensive portfolio of pharmaceutical products designed to address diverse medical conditions. Its established presence in India's pharmaceutical market reflects its commitment to improving health outcomes across the country.
HDFC Life Insurance Company Limited, institutional investor in Indian equities
